Key result
Mahoney Type 1 infective fraction fixes complement well but soluble antigen fixes far less than MEF1.
Answers are grounded in this paper and cite their sources.
Strain differences in poliovirus soluble antigen complement fixation may inform serologic assay design; leaves open diagnostic and antigenic characterization needs.
Good fixation of complement was obtained with the infective virus fraction of the Mahoney Type 1 poliomyelitis virus which had been adapted to suckling mice. The presence of a soluble antigen, specific to Type 1 virus, was also demonstrated but was small in amount. The infective virus fraction of the suckling mouse adapted MEF1 Type 2 poliomyelitis virus produced as good fixation of complement as did Type 1, but the fixation of complement by the MEF1 soluble antigen was far greater than that obtained with the Mahoney strain. The author would like to thank Prof. A. Kipps for his interest and encouragement and Miss M. Butchart for her valuable technical assistance. She is also indebted to Dr H. Malherbe of the Poliomyelitis Research Foundation, Johannesburg, for the Type 1 monkey immune serum.
No takes yet. Share an insight, caveat, or question.
Golda Selzer (1959) studied Poliomyelitis virus infection (laboratory model). Mahoney Type 1 poliomyelitis virus antigen vs. MEF1 Type 2 poliomyelitis virus antigen was evaluated on Complement-fixation titre. The infective virus fraction of suckling mouse-adapted Mahoney Type 1 poliovirus produced good complement fixation, but its soluble antigen fixed far less complement than the MEF1 Type 2 strain.
Synapse has enriched 10 related papers. Consider them for comparative context: